Dr. Min Hu, Australia
Correlation of dynamic immune cell profile with individual alloresponse and outcome in type 1 diabetes islet transplantation recipients

Chris J Drogemuller, Australia
Australian experience of total pancreatectomy and islet auto transplant (TPIAT) utilizing a remote isolation center

Mr. Shiva Pathak, Korea
Development of a highly effective protocol using local immune suppression strategy in pancreatic islet transplantation

Dr. Ming Han Yao, Sweden
Improvement of metabolic function after intra-portal allogeneic islet transplantation using induction treatment of the non-hematopoetic erythropoietin analogue cibinetide in a mouse model

Dr. Ji Yoon Choi, Korea
The effect of steroid maintenance in recipients with pancreas transplant alone: A single center experience

Dr. Jeffrey M Stern, United States
Antibody mediated rejection due to de-novo DSA causing venous thrombosis of pancreas allograft – a case report

Dr. Espen Nordheim, Norway
Preserved insulin sensitivity and kidney function one year after successful pancreas transplantation

Prof. Marek Durlik, Poland
Endoscopic intervention can prevent reoperation in patients after pancreas transplantation – the advantage of the duodenoduodenal anastomosis

Ms. Barbora Voglova, Czech Republic
Update on clinical trial EMA – SPK: Everolimus verus mycophenolic acid in simultaneous pancreas and kidney transplantation to evaluate the differencies in retinal neovascularisation in patients with diabetic retinopathy

Mrs. Agnieszka Surowiecka-Pastewka, Poland
Impact of peritoneal dialysis on SPK results

Mrs. Agnieszka Surowiecka-Pastewka, Poland
Pancreas graftectomy predicting markers

Dr. Marta Matejak-Górska, Poland
Delayed pancreas graft function –a challenge for clinicians

Dr. Marta Matejak-Górska, Poland
Role of intravascular interventions in simultaneous pancreas and kidney transplantation - almost 15 years of experience